DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ rose 3.39% to $11.28 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.03% to 26,099.77 and Dow Jones Industrial Average falling 0.79% to 52,766.88.
Corbus Pharmaceuticals Holdings Inc. closed 45.14% short of its 52-week high of $20.56, which the company reached on October 20th.
The stock outperformed some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 0.37% to $5.42, Fortress Biotech Inc. (FBIO) fell 2.01% to $2.68, and Viking Therapeutics Inc. (VKTX) rose 2.72% to $33.67.
Trading volume (900,284) eclipsed its 50-day average volume of 433,524.
Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.